Gemma Biotherapeutics, Inc.

Danielle Kaczinski signed Gemma Biotherapeutics, Inc.'s 2024 Form 5500 as plan administrator.

• Danielle Kaczinski — Plan Administrator — Form 5500 signer

Signer names are public record from the Form 5500 e-signature.

Gemma Biotherapeutics, Inc.'s EIN is 88-2835041.

Download the official 2024 Form 5500 (PDF) for Gemma Biotherapeutics, Inc. from the U.S. Department of Labor's EFAST2 system.

Gemma Biotherapeutics, Inc.'s plan includes profit-sharing, a 401(k) feature, ERISA 404(c) participant direction, a default investment (QDIA).